PhD defence Alessandra Buoninfante: DNA damage tolerance and personalized cancer medicine

04-07-2018

Alessandra Buoninfante studied the overall relevance of the DNA-damage tolerance (DDT) pathways for mammals and its contribution to hematopoietic stem cell maintenance and tissue homeostasis, reporting a new embryonic and synthetic lethality. Moreover, she unveiled that tumor-specific DDT-aberrations can be exploited to predict tumor responsiveness and improve sequencing-based personalized cancer medicine.

 

Alessandra Buoninfante

Alessandra Buoninfante will publicly defend her thesis at the University of Amsterdam on Thursday the 5th of July.

A. Buoninfante: Physiological and pharmacological relevance of DNA damage tolerance.

Supervisor: Prof. dr. J. Borst (Netherlands Cancer Institute and University of Amsterdam) Co-supervisor:  Dr. H.B. Jacobs (Netherlands Cancer Institute)

Information about the PhD-defence and summary of the thesis on the website of the University of Amsterdam.

 

Other tumors

Support our science?

Learn more
Disclaimer
Privacy statement
Cookies
Change cookie settings